According to Balkan Insight, “After receiving the first batches of the vaccine acquired by Brussels, EU member states in Central and Eastern Europe on Sunday started COVID-19 vaccination campaigns with symbolic ceremonies that left images of hope following months of fear. As in the rest of the EU, health workers, politicians and civil society leaders trying to dispel popular distrust of vaccines were chosen to take the first jabs in symbolic ceremonies designed to kickstart national vaccination campaigns across the region.
COVID-19 vaccine considerations for Georgia
- Can employers mandate the vaccine?
It will depend on the industry and employees’ job responsibilities.
- Who will control delivery of the vaccine?
- Who covers the cost of the vaccine?
- Where will people get vaccinated?
Government designated vaccination locations
- Is there cultural resistance to getting the vaccine?
Georgia’s First Deputy Health Minister presented on January 21 some of the “key aspects” of Georgia’s national COVID-19 vaccination plan, approved by the Government earlier during the day. Although missing the precise data, including specific date of the start of rollout, as well as the name of the vaccine, the plan envisages immunizing approximately 60% of the population over 18 – 1.7 million citizens by the end of 2021. Importantly, the plan only allows using vaccines approved by the World Health Organization, or either of the top 37 national regulatory bodies, including U.S., EU, UK, Australia and Japan agencies. According to the Government plan, the costs necessary to immunize 60% of the population in 2021 will range from GEL 64.3 million (USD 19.5 million) to GEL 158.1 million (USD 47.8 million).
More InformationGrECo Group, Asinta's partner in Georgia.
Employee Benefits in Georgia
Get insights on mandatory and common supplementary employee benefits in Georgia.
Top 6 Vaccine Considerations
Use our decision matrix to help support your employees.
Page last modified: February 10, 2021
The information presented on this site is current as of the date initially posted; and, because matters related to COVID-19, the vaccine, and compliance measures are changing so quickly, it may not be current as of the date you read it. While the information gathered here is from Asinta global partners who are subject matter experts in their respective fields, this information is not meant to be a substitute for individual legal or medical advice, or as a substitute for advice in your specific situation.